Karyopharm Therapeutics Inc (NASDAQ:KPTI)

8.30
Delayed Data
As of Jul 19
 -0.07 / -0.84%
Today’s Change
3.92
Today|||52-Week Range
21.71
-11.42%
Year-to-Date

Today’s Trading

Previous close8.37
Today’s open8.39
Day’s range8.10 - 8.41
Volume1,243,496
Average volume (3 months)1,921,618
Market cap$505.2M
Data as of 3:59pm ET, 07/19/2019

Growth & Valuation

Earnings growth (last year)-11.78%
Earnings growth (this year)-19.85%
Earnings growth (next 5 years)-49.42%
Revenue growth (last year)+1,790.09%
P/E ratioNM
Price/Sales17.54
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
EOLSEvolus Inc-0.87-4.38%
CTMXCytomX Therapeutics ...-0.63-5.14%
GLYCGlycoMimetics Inc-0.71-5.98%
MISTMilestone Pharmaceut...+0.31+1.62%
Data as of 4:00pm ET, 07/19/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$30.3M
Annual profit (last year)-$178.4M
Net profit margin-588.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts